Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buyang Huanwu Decoction Combined With Wuling Powder for Acute Ischemic Stroke
NCT07687043Completed
- Sponsor
- Liaoning University of Traditional Chinese Medicine
- Start
- Mar 2023
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial of buyang huanwu decoction and wulingshen in ischemic stroke (3 arms), sponsored by Liaoning University of Traditional Chinese Medicine. Primary endpoints: National Institutes of Health Stroke Scale at Day 14, Barthel Index at Day 14 and 1 more. Started Mar 2023; status: completed.
02
Drugs
buyang huanwu decoctionwulingshen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07687043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07687043.